The anti-tumor effects of cetuximab in combination with VTX-2337 are T cell dependent. - Cheng Y; Borcherding N; Ogunsakin A; Lemke-Miltner CD; Gibson-Corley KN; Rajan A; Choi AB; Wongpattaraworakul W; Chan CHF; Salem AK; Weiner GJ; Simons AL (Scientific reports, 2021)